Delivery Order SPE2DB20D1109-SPE2DB24FP96P
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick autoinjectors. The $1,794.42 firm fixed-price contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,039.08 firm fixed-price contract is for the delivery of the specialty medication Repatha (Evolocumab) 140 mg/mL SureClick injector. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Repatha (140 mg/mL SureClick). The contract has a firm fixed price of $1,041.42 and a period of performance through May 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha 140 mg/mL SureClick injectors. The $1,355.76 firm-fixed-price contract has a completion date of September 9, 2024. This award is not associated with a specific set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a broad range of...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $3,777.43 firm-fixed-price contract is for the supply of Repatha (evolocumab) 140mg/ml SureClick injectors. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. This delivery order falls under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support...
- This contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $6,139.14 firm fixed-price Delivery Order is for the supply of Repatha (evolocumab) 140 mg/mL SureClick injectors. The contract has a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (evolocumab) 140 mg/mL SureClick autoinjectors. The $1,801.86 firm-fixed-price contract has a period of performance through July 2, 2024 and was not designated as a set-aside requirement. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $2,559.06, is for the supply of Repatha 140 mg/mL SureClick injectors, a specialty pharmaceutical product. The order is placed under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, which enables the agency to efficiently procure a wide range of medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Repatha (evolocumab) 140 mg/mL SureClick injectors. The $2,461.42 firm fixed-price delivery order has an ultimate completion date of October 21, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
- This is a $1,016.88 delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Repatha (140 mg/ml) SureClick injectors. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs and facilities...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FP96PDelivery Order
This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under their Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract is for the supply of Repatha (evolocumab) 140 mg/mL SureClick injectors, a specialty medication used for cardiovascular disease treatment. The Delivery Order has a firm fixed price of $1,016.82 and a completion date of September 25, 2024. There is no set-aside designation indicated for this award. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support the DLA and other federal agencies through these long-term IDC contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/24/24 |